I reported previously (see here) on new Israeli treatments for Acute Myeloid Leukemia (AML). Now the Hebrew University of Jerusalem and US biotech BioTheryX are developing a single molecule that attacks multiple leukemia proteins simultaneously. Lab tests show a 50% success rate.

https://www.timesofisrael.com/new-drug-brings-hope-in-acute-leukemia-battle-hebrew-u-researchers-say/

http://www.jewishpress.com/news/israel/hebrew-u-drug-trials-show-50-cure-rate-in-lab-mice-acute-leukemia/2018/08/27/